- Home
- PRME vs ASPI Comparison
PRME vs ASPI Comparison
Compare PRME & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | ASPI |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 639.3M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PRME | ASPI |
|---|---|---|
| Price | $3.56 | $4.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $7.56 | ★ $12.00 |
| AVG Volume (30 Days) | 2.6M | ★ 4.1M |
| Earning Date | 03-03-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,632,000.00 | $4,144,226.00 |
| Revenue This Year | $15.20 | $108.31 |
| Revenue Next Year | $316.23 | $403.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 55.28 | ★ 857.04 |
| 52 Week Low | $1.11 | $3.92 |
| 52 Week High | $6.94 | $14.49 |
Technical Indicators
Market Signals| Indicator | PRME | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 32.18 |
| Support Level | $3.19 | N/A |
| Resistance Level | $4.74 | $6.20 |
| Average True Range (ATR) | 0.26 | 0.53 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 9.46 | 3.11 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.